Your browser doesn't support javascript.
loading
Efficacy and safety of proprotein convertase subtilisin/kexin type 9 monoclonal antibody in adults with familial hypercholesterolemia.
Li, Bin; Hao, Pan-Pan; Zhang, Yong; Yin, Rui-Hong; Kong, Qing-Zan; Cai, Xiao-Jun; Zhao, Zhuo; Qi, Jian-Ni; Li, Ying; Xiao, Jie; Wang, Fu; Yi, Wei; Ji, Xiao-Ping; Su, Guo-Hai.
Afiliación
  • Li B; Department of Cardiology, Jinan Central Hospital affiliated to Shandong University, Jinan, Shandong, China.
  • Hao PP; Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, Department of Cardiology, Shandong University Qilu Hospital, Jinan, Shandong, China.
  • Zhang Y; Department of Neurology, Jinan Central Hospital affiliated to Shandong University, Jinan, Shandong, China.
  • Yin RH; Department of Gastroenterology, First People's Hospital of Jinan, Jinan, Shandong, China.
  • Kong QZ; Department of Cardiology, Jinan Central Hospital affiliated to Shandong University, Jinan, Shandong, China.
  • Cai XJ; Department of Cardiology, Jinan Central Hospital affiliated to Shandong University, Jinan, Shandong, China.
  • Zhao Z; Department of Cardiology, Jinan Central Hospital affiliated to Shandong University, Jinan, Shandong, China.
  • Qi JN; Central Laboratory, Shandong Provincial Hospital affiliated to Shandong University, Jinan, Shandong, China.
  • Li Y; Central Laboratory, Jinan Central Hospital affiliated to Shandong University, Jinan, Shandong, China.
  • Xiao J; Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, Department of Cardiology, Shandong University Qilu Hospital, Jinan, Shandong, China.
  • Wang F; Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, Department of Cardiology, Shandong University Qilu Hospital, Jinan, Shandong, China.
  • Yi W; Engineering Training Center, Shandong University, Jinan, Shandong, China.
  • Ji XP; Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, Department of Cardiology, Shandong University Qilu Hospital, Jinan, Shandong, China.
  • Su GH; Department of Cardiology, Jinan Central Hospital affiliated to Shandong University, Jinan, Shandong, China.
Oncotarget ; 8(18): 30455-30463, 2017 May 02.
Article en En | MEDLINE | ID: mdl-27458166
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de PCSK9 / Hiperlipoproteinemia Tipo II / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Guideline / Systematic_reviews Límite: Animals / Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de PCSK9 / Hiperlipoproteinemia Tipo II / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Guideline / Systematic_reviews Límite: Animals / Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos